NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,458 | -59.3% | 21,923 | -1.4% | 0.00% | – |
| Q2 2023 | $57,583 | -50.6% | 22,233 | -22.2% | 0.00% | – |
| Q1 2023 | $116,590 | -17.9% | 28,576 | +1.1% | 0.00% | – |
| Q4 2022 | $141,930 | -88.7% | 28,273 | -70.5% | 0.00% | -100.0% |
| Q3 2022 | $1,252,000 | +37.6% | 95,686 | +34.8% | 0.00% | 0.0% |
| Q2 2022 | $910,000 | -5.1% | 70,996 | +12.9% | 0.00% | 0.0% |
| Q1 2022 | $959,000 | -59.1% | 62,888 | -22.1% | 0.00% | -50.0% |
| Q1 2021 | $2,346,000 | +25.1% | 80,692 | +30.4% | 0.00% | 0.0% |
| Q4 2020 | $1,875,000 | +83.3% | 61,875 | -3.7% | 0.00% | +100.0% |
| Q3 2020 | $1,023,000 | -10.5% | 64,282 | +11.0% | 0.00% | -50.0% |
| Q2 2020 | $1,143,000 | – | 57,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |